Sancycline Hydrochloride

LABA/LAMAROUTE OF ADMINISTRATION: Inhalation
REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Oral, Injectable

REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Injectable

REGULATORY STATUS: DEV, TECH PACK

A very high purity grade product available from a reliable European source

ROUTE OF ADMINISTRATION: Oral

REGULATORY STATUS: CEP, JP DMF

LABA/ LAMAROUTE OF ADMINISTRATION: Inhalation
REGULATORY STATUS: GMP, TECH PACK

Hovione has a proven track record in developing and manufacturing high performance APIs for the most demanding applications such as inhalation. With an unrivalled range of particle size reduction technologies for the production of tailor made API, featuring a near-perfect particle size distribution re...

ROUTE OF ADMINISTRATION: Oral

REGULATORY STATUS: DEV

ROUTE OF ADMINISTRATION: Injectable

REGULATORY STATUS: DEV, TECH PACK

 Tiotropium Bromide for development trials with customized Particle Design, manufactured by wet polishing, resulting in Inhalation grade material with highly customizable PSD to befit your application.
Our technology and expertise range yields unmatched impurity profiles with highly reproducib...

Umeclidinium Bromide for formulation development trials with customized Particle Engineering, resulting in Inhalation grade material with highly customizable PSD to enhance your formulation’s performance. Our technology and expertise yields unmatched impurity profiles with highly reproducibility betwe...

Vilanterol Trifenatate for development trials with customized Particle Design, resulting in Inhalation grade material with highly customizable PSD to befit your application.
Our technology and expertise range yields unmatched impurity profiles with highly reproducibility between batches, r...

Hovione helps you bring new medicines to patients in an unprecedented speed.

As a fully integrated CDMO, we offer over 60 years’ experience in chemical process development and manufacture of APIs. Our more recent capabilities in Drug Product together with our innovative science, the most up-to-...

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.

Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®

Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler.